<?xml version="1.0" encoding="UTF-8"?>

<modsCollection xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
<mods version="3.3">

<genre>article</genre>

<titleInfo><title>Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment</title></titleInfo>


<note type="publicationStatus">published</note>


<note type="qualityControlled">yes</note>

<name type="personal">
  <namePart type="given">Margaret E</namePart>
  <namePart type="family">Maes</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">3838F452-F248-11E8-B48F-1D18A9856A87</identifier><description xsi:type="identifierDefinition" type="orcid">0000-0001-9642-1085</description></name>
<name type="personal">
  <namePart type="given">Gabriele M.</namePart>
  <namePart type="family">Wögenstein</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Gloria</namePart>
  <namePart type="family">Colombo</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">3483CF6C-F248-11E8-B48F-1D18A9856A87</identifier><description xsi:type="identifierDefinition" type="orcid">0000-0001-9434-8902</description></name>
<name type="personal">
  <namePart type="given">Raquel</namePart>
  <namePart type="family">Casado Polanco</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">15240fc1-dbcd-11ea-9d1d-ac5a786425fd</identifier><description xsi:type="identifierDefinition" type="orcid">0000-0001-8293-4568</description></name>
<name type="personal">
  <namePart type="given">Sandra</namePart>
  <namePart type="family">Siegert</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">36ACD32E-F248-11E8-B48F-1D18A9856A87</identifier><description xsi:type="identifierDefinition" type="orcid">0000-0001-8635-0877</description></name>







<name type="corporate">
  <namePart></namePart>
  <identifier type="local">SaSi</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>

<name type="corporate">
  <namePart></namePart>
  <identifier type="local">SiHi</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>





<name type="corporate">
  <namePart>Microglia action towards neuronal circuit formation and function in health and disease</namePart>
  <role><roleTerm type="text">project</roleTerm></role>
</name>



<abstract lang="eng">Adeno-associated viruses (AAVs) are widely used to deliver genetic material in vivo to distinct cell types such as neurons or glial cells, allowing for targeted manipulation. Transduction of microglia is mostly excluded from this strategy, likely due to the cells’ heterogeneous state upon environmental changes, which makes AAV design challenging. Here, we established the retina as a model system for microglial AAV validation and optimization. First, we show that AAV2/6 transduced microglia in both synaptic layers, where layer preference corresponds to the intravitreal or subretinal delivery method. Surprisingly, we observed significantly enhanced microglial transduction during photoreceptor degeneration. Thus, we modified the AAV6 capsid to reduce heparin binding by introducing four point mutations (K531E, R576Q, K493S, and K459S), resulting in increased microglial transduction in the outer plexiform layer. Finally, to improve microglial-specific transduction, we validated a Cre-dependent transgene delivery cassette for use in combination with the Cx3cr1CreERT2 mouse line. Together, our results provide a foundation for future studies optimizing AAV-mediated microglia transduction and highlight that environmental conditions influence microglial transduction efficiency.
</abstract>

<relatedItem type="constituent">
  <location>
    <url displayLabel="2021_MolTherMethodsClinDev_Maes.pdf">https://research-explorer.ista.ac.at/download/10655/10657/2021_MolTherMethodsClinDev_Maes.pdf</url>
  </location>
  <physicalDescription><internetMediaType>application/pdf</internetMediaType></physicalDescription><accessCondition type="restrictionOnAccess">no</accessCondition>
</relatedItem>
<originInfo><publisher>Elsevier</publisher><dateIssued encoding="w3cdtf">2021</dateIssued>
</originInfo>
<language><languageTerm authority="iso639-2b" type="code">eng</languageTerm>
</language>



<relatedItem type="host"><titleInfo><title>Molecular Therapy - Methods and Clinical Development</title></titleInfo>
  <identifier type="eIssn">2329-0501</identifier>
  <identifier type="ISI">000748748500019</identifier><identifier type="doi">10.1016/j.omtm.2021.09.006</identifier>
<part><detail type="volume"><number>23</number></detail><extent unit="pages">210-224</extent>
</part>
</relatedItem>


<extension>
<bibliographicCitation>
<ama>Maes ME, Wögenstein GM, Colombo G, Casado Polanco R, Siegert S. Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment. &lt;i&gt;Molecular Therapy - Methods and Clinical Development&lt;/i&gt;. 2021;23:210-224. doi:&lt;a href=&quot;https://doi.org/10.1016/j.omtm.2021.09.006&quot;&gt;10.1016/j.omtm.2021.09.006&lt;/a&gt;</ama>
<short>M.E. Maes, G.M. Wögenstein, G. Colombo, R. Casado Polanco, S. Siegert, Molecular Therapy - Methods and Clinical Development 23 (2021) 210–224.</short>
<ieee>M. E. Maes, G. M. Wögenstein, G. Colombo, R. Casado Polanco, and S. Siegert, “Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment,” &lt;i&gt;Molecular Therapy - Methods and Clinical Development&lt;/i&gt;, vol. 23. Elsevier, pp. 210–224, 2021.</ieee>
<chicago>Maes, Margaret E, Gabriele M. Wögenstein, Gloria Colombo, Raquel Casado Polanco, and Sandra Siegert. “Optimizing AAV2/6 Microglial Targeting Identified Enhanced Efficiency in the Photoreceptor Degenerative Environment.” &lt;i&gt;Molecular Therapy - Methods and Clinical Development&lt;/i&gt;. Elsevier, 2021. &lt;a href=&quot;https://doi.org/10.1016/j.omtm.2021.09.006&quot;&gt;https://doi.org/10.1016/j.omtm.2021.09.006&lt;/a&gt;.</chicago>
<ista>Maes ME, Wögenstein GM, Colombo G, Casado Polanco R, Siegert S. 2021. Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment. Molecular Therapy - Methods and Clinical Development. 23, 210–224.</ista>
<mla>Maes, Margaret E., et al. “Optimizing AAV2/6 Microglial Targeting Identified Enhanced Efficiency in the Photoreceptor Degenerative Environment.” &lt;i&gt;Molecular Therapy - Methods and Clinical Development&lt;/i&gt;, vol. 23, Elsevier, 2021, pp. 210–24, doi:&lt;a href=&quot;https://doi.org/10.1016/j.omtm.2021.09.006&quot;&gt;10.1016/j.omtm.2021.09.006&lt;/a&gt;.</mla>
<apa>Maes, M. E., Wögenstein, G. M., Colombo, G., Casado Polanco, R., &amp;#38; Siegert, S. (2021). Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment. &lt;i&gt;Molecular Therapy - Methods and Clinical Development&lt;/i&gt;. Elsevier. &lt;a href=&quot;https://doi.org/10.1016/j.omtm.2021.09.006&quot;&gt;https://doi.org/10.1016/j.omtm.2021.09.006&lt;/a&gt;</apa>
</bibliographicCitation>
</extension>
<recordInfo><recordIdentifier>10655</recordIdentifier><recordCreationDate encoding="w3cdtf">2022-01-23T23:01:28Z</recordCreationDate><recordChangeDate encoding="w3cdtf">2025-04-14T07:41:46Z</recordChangeDate>
</recordInfo>
</mods>
</modsCollection>
